THE GREENROSE HOLDING COMPANY INC. The Greenrose Holding Company Inc. Share Price
Equities
GNRS
US3953921034
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0001 USD | -50.00% |
|
-50.00% | -75.00% |
| 2023 | The Greenrose Holding Company Inc. Announces CEO Changes | CI |
| 2023 | The Greenrose Holding Company Inc. Terminates Bernard Wang as the Chief Financial Officer | CI |
| Sales 2020 | - | Sales 2021 | 23.12 1.84K | Capitalization | 71.15M 5.68B |
|---|---|---|---|---|---|
| Net income 2020 | - 0 | Net income 2021 | 83M 6.62B | EV / Sales 2020 | - |
| Net Debt 2020 | 690K 55.06M | Net Debt 2021 | 99.72M 7.96B | EV / Sales 2021 | 7,389,406 x |
| P/E ratio 2020 |
-502
x | P/E ratio 2021 |
0.82
x | Employees | 91 |
| Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -50.00% | ||
| 1 week | -50.00% | ||
| 3 months | -90.00% | ||
| 6 months | -83.33% | ||
| Current year | -75.00% |
1 month
0.00
0.00
Current year
0.000.00
1 year
0.000.69
3 years
0.0010.62
5 years
0.0011.46
10 years
0.0011.46
| Managers | Title | Age | Since |
|---|---|---|---|
Nicole Conboy
CEO | Chief Executive Officer | 59 | 30/11/20 |
Daniel Harley
BRD | Director/Board Member | 59 | 25/08/19 |
Brendan Sheehan
BRD | Director/Board Member | 53 | 25/08/19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Thomas Lynch
BRD | Director/Board Member | 56 | 08/10/22 |
William Harley
BRD | Director/Board Member | 60 | 25/08/19 |
Jarom Fawson
BRD | Director/Board Member | 50 | 08/10/22 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/04/24 | 0.0001 | -50.00% | 101,967 |
Delayed Quote OTC Markets, April 23, 2024 at 06:38 pm
More quotes
The Greenrose Holding Company Inc. is a multi-state cultivator and producer of cannabis brands and products. The Company, through its subsidiaries, Theraplant, LLC and True Harvest LLC is engaged in the manufacture and processing of cannabis in the adult-use and medical cannabis marketplace in Connecticut and Arizona. It owns and operates cannabis businesses or has management or consulting services or other agreements to assist in operations with licensed operators. The Company is focused on providing access to the cannabis and cannabinoid-based products through cultivation and processing facilities and customer engagement channels, in store, online and at home. Its primary areas of focus include cultivation and genetics; retail and distribution; processing/manufacturing; wholesale; and data and insights. The Company has approximately 63,500 square feet of canopy for cannabis cultivation.
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -75.00% | 1.77K | |
| +46.09% | 375M | |
| +30.93% | 313M | |
| +53.49% | 220M | |
| -28.99% | 183M | |
| +56.76% | 171M | |
| -28.57% | 144M | |
| +148.33% | 123M | |
| +3.85% | 106M | |
| +150.00% | 75.33M |
- Stock Market
- Equities
- GNRS Stock
